Gilead Keeps Dealing With $300M OncoNano Drug Delivery Cancer Pact

By /

OncoNano’s platform, called ON-BOARD, packages drugs in pH-sensitive micelles that ensure their specific delivery near tumors, while also preventing systemic exposure.

Scroll to Top